MTOR and neoplasm: The results showed that SSGs can attenuate the differentiation of bone marrow by inhibiting the mTOR signal pathway in the bone marrow microenvironment and decrease the systemic levels of MDSCs in the bone marrow, blood, and lungs, suggesting that SSGs not only have an inhibitory effect on tumor cell proliferation but also have a protective effect against lung metastasis.